92 related articles for article (PubMed ID: 24362790)
1. TAT-RasGAP317-326-mediated tumor cell death sensitization can occur independently of Bax and Bak.
Annibaldi A; Heulot M; Martinou JC; Widmann C
Apoptosis; 2014 Apr; 19(4):719-33. PubMed ID: 24362790
[TBL] [Abstract][Full Text] [Related]
2. TAT-RasGAP317-326 requires p53 and PUMA to sensitize tumor cells to genotoxins.
Michod D; Widmann C
Mol Cancer Res; 2007 May; 5(5):497-507. PubMed ID: 17510315
[TBL] [Abstract][Full Text] [Related]
3. Effect of RasGAP N2 fragment-derived peptide on tumor growth in mice.
Michod D; Annibaldi A; Schaefer S; Dapples C; Rochat B; Widmann C
J Natl Cancer Inst; 2009 Jun; 101(11):828-32. PubMed ID: 19470951
[TBL] [Abstract][Full Text] [Related]
4. The TAT-RasGAP317-326 anti-cancer peptide can kill in a caspase-, apoptosis-, and necroptosis-independent manner.
Heulot M; Chevalier N; Puyal J; Margue C; Michel S; Kreis S; Kulms D; Barras D; Nahimana A; Widmann C
Oncotarget; 2016 Sep; 7(39):64342-64359. PubMed ID: 27602963
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the chemosensitizing activity of TAT-RasGAP317-326 in childhood cancers.
Chevalier N; Gross N; Widmann C
PLoS One; 2015; 10(3):e0120487. PubMed ID: 25826368
[TBL] [Abstract][Full Text] [Related]
6. A WXW motif is required for the anticancer activity of the TAT-RasGAP317-326 peptide.
Barras D; Chevalier N; Zoete V; Dempsey R; Lapouge K; Olayioye MA; Michielin O; Widmann C
J Biol Chem; 2014 Aug; 289(34):23701-11. PubMed ID: 25008324
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells.
Matsumoto M; Nakajima W; Seike M; Gemma A; Tanaka N
Biochem Biophys Res Commun; 2016 Apr; 473(2):490-6. PubMed ID: 26996126
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cell migration and invasion mediated by the TAT-RasGAP317-326 peptide requires the DLC1 tumor suppressor.
Barras D; Lorusso G; Rüegg C; Widmann C
Oncogene; 2014 Oct; 33(44):5163-72. PubMed ID: 24213569
[TBL] [Abstract][Full Text] [Related]
9. Platinum(IV) complex LA-12 exerts higher ability than cisplatin to enhance TRAIL-induced cancer cell apoptosis via stimulation of mitochondrial pathway.
Jelínková I; Šafaříková B; Vondálová Blanářová O; Skender B; Hofmanová J; Sova P; Moyer MP; Kozubík A; Kolář Z; Ehrmann J; Hyršlová Vaculová A
Biochem Pharmacol; 2014 Dec; 92(3):415-24. PubMed ID: 25285768
[TBL] [Abstract][Full Text] [Related]
10. TAT-RasGAP
Tsoutsou P; Annibaldi A; Viertl D; Ollivier J; Buchegger F; Vozenin MC; Bourhis J; Widmann C; Matzinger O
Radiat Res; 2017 May; 187(5):562-569. PubMed ID: 28323576
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53.
Jones NA; Turner J; McIlwrath AJ; Brown R; Dive C
Mol Pharmacol; 1998 May; 53(5):819-26. PubMed ID: 9584207
[TBL] [Abstract][Full Text] [Related]
12. Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death.
Tajeddine N; Galluzzi L; Kepp O; Hangen E; Morselli E; Senovilla L; Araujo N; Pinna G; Larochette N; Zamzami N; Modjtahedi N; Harel-Bellan A; Kroemer G
Oncogene; 2008 Jul; 27(30):4221-32. PubMed ID: 18362892
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial p53 phosphorylation induces Bak-mediated and caspase-independent cell death.
Wang J; Guo W; Zhou H; Luo N; Nie C; Zhao X; Yuan Z; Liu X; Wei Y
Oncotarget; 2015 Jul; 6(19):17192-205. PubMed ID: 25980443
[TBL] [Abstract][Full Text] [Related]
14. Bax and Bak genes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa.
Shankar S; Srivastava RK
Carcinogenesis; 2007 Jun; 28(6):1277-86. PubMed ID: 17277231
[TBL] [Abstract][Full Text] [Related]
15. A RasGAP-derived cell permeable peptide potently enhances genotoxin-induced cytotoxicity in tumor cells.
Michod D; Yang JY; Chen J; Bonny C; Widmann C
Oncogene; 2004 Nov; 23(55):8971-8. PubMed ID: 15467750
[TBL] [Abstract][Full Text] [Related]
16. Acquired resistance to rituximab is associated with chemotherapy resistance resulting from decreased Bax and Bak expression.
Olejniczak SH; Hernandez-Ilizaliturri FJ; Clements JL; Czuczman MS
Clin Cancer Res; 2008 Mar; 14(5):1550-60. PubMed ID: 18316580
[TBL] [Abstract][Full Text] [Related]
17. Tumor suppressor protein p53 promotes 2-methoxyestradiol-induced activation of Bak and Bax, leading to mitochondria-dependent apoptosis in human colon cancer HCT116 cells.
Lee JY; Jee SB; Park WY; Choi YJ; Kim B; Kim YH; Jun do Y; Kim YH
J Microbiol Biotechnol; 2014 Dec; 24(12):1654-63. PubMed ID: 25179905
[TBL] [Abstract][Full Text] [Related]
18. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
Kandasamy K; Srinivasula SM; Alnemri ES; Thompson CB; Korsmeyer SJ; Bryant JL; Srivastava RK
Cancer Res; 2003 Apr; 63(7):1712-21. PubMed ID: 12670926
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of VDAC1 sensitizes carcinoma cells to apoptosis induced by DNA cross-linking agents.
Sharaf el dein O; Gallerne C; Brenner C; Lemaire C
Biochem Pharmacol; 2012 May; 83(9):1172-82. PubMed ID: 22285227
[TBL] [Abstract][Full Text] [Related]
20. A high-throughput image-based screen for the identification of Bax/Bak-independent caspase activators against drug-resistant cancer cells.
Seervi M; Sobhan PK; Mathew KA; Joseph J; Pillai PR; Santhoshkumar TR
Apoptosis; 2014 Jan; 19(1):269-84. PubMed ID: 24220853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
